Evidence map›Paper›PMID 36816405›Full record

ArticleFrontiers in psychiatry2023

Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid.

Vladimir Adrien, Nicolas Bosc, Hugo Fumat, Cédric Tessier, Florian Ferreri, Stéphane Mouchabac, David Tareste, Philippe Nuss

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Vladimir AdrienAP-HP, Sorbonne Université, Department of Psychiatry, Hôpital Saint-Antoine, Paris, France.
Nicolas BoscAP-HP, Sorbonne Université, Department of Psychiatry, Hôpital Saint-Antoine, Paris, France.
Hugo FumatUniversité Paris Cité, INSERM UMR-S 1266, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Cédric TessierAP-HP, Sorbonne Université, Department of Psychiatry, Hôpital Saint-Antoine, Paris, France.
Florian FerreriAP-HP, Sorbonne Université, Department of Psychiatry, Hôpital Saint-Antoine, Paris, France.
Stéphane MouchabacAP-HP, Sorbonne Université, Department of Psychiatry, Hôpital Saint-Antoine, Paris, France.
David TaresteUniversité Paris Cité, INSERM UMR-S 1266, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Philippe NussAP-HP, Sorbonne Université, Department of Psychiatry, Hôpital Saint-Antoine, Paris, France.
Hôpital Saint-Antoine · FRInserm · FRInstitut de Psychiatrie et Neurosciences de Paris · FRInstitut du Cerveau · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is a severe, chronic, and heterogeneous mental disorder that affects approximately 1% of the world population. Ongoing research aims at clustering schizophrenia heterogeneity into various "biotypes" to identify subgroups of individuals displaying homogeneous symptoms, etiopathogenesis, prognosis, and treatment response. The present study is in line with this approach and focuses on a biotype partly characterized by a specific membrane lipid composition. We have examined clinical and biological data of patients with stabilized schizophrenia, including the fatty acid content of their erythrocyte membranes, in particular the omega-3 docosahexaenoic acid (DHA). Two groups of patients of similar size were identified: the DHA- group (

Indexed as

biomarkersmembrane fatty acidsquality of lifeschizophreniastabilized patients

Identifiers

PMID36816405
PMCPMC9937080
OpenAlexW4319161869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.